FDA Inspection 992510 — BLI International, Inc.

BLI International, Inc. — FEI 3001195380

The FDA completed an inspection of BLI International, Inc. on November 2, 2016 in Deer Park, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 2, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Deer Park, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
180921 CFR 211.160(a)Following/documenting laboratory controls
355621 CFR 211.50Sewage and refuse disposal in safe manner
362921 CFR 211.170(b)Reserve samples identified, representative, stored
434021 CFR 211.142Written warehousing procedures established/followed
434221 CFR 211.142(b)Storage under appropriate conditions